mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.03 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.04 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.04 |